Suppr超能文献

遏制慢性肾脏病流行:全球监测工作概览

Taming the chronic kidney disease epidemic: a global view of surveillance efforts.

作者信息

Radhakrishnan Jai, Remuzzi Giuseppe, Saran Rajiv, Williams Desmond E, Rios-Burrows Nilka, Powe Neil, Brück Katharina, Wanner Christoph, Stel Vianda S, Venuthurupalli Sree K, Hoy Wendy E, Healy Helen G, Salisbury Anne, Fassett Robert G, O'Donoghue Donal, Roderick Paul, Matsuo Seiichi, Hishida Akira, Imai Enyu, Iimuro Satoshi

机构信息

Division of Nephrology, Department of Medicine, Columbia University Medical Center, New York, New York, USA.

Azienda Ospedaliera Papa Giovanni XXIII, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Bergamo, Italy.

出版信息

Kidney Int. 2014 Aug;86(2):246-50. doi: 10.1038/ki.2014.190. Epub 2014 Jun 4.

Abstract

Chronic kidney disease is now recognized to be a worldwide problem associated with significant morbidity and mortality and there is a steep increase in the number of patients reaching end-stage renal disease. In many parts of the world, the disease affects younger people without diabetes or hypertension. The costs to family and society can be enormous. Early recognition of CKD may help prevent disease progression and the subsequent decline in health and longevity. Surveillance programs for early CKD detection are beginning to be implemented in a few countries. In this article, we will focus on the challenges and successes of these programs with the hope that their eventual and widespread use will reduce the complications, deaths, disabilities, and economic burdens associated with CKD worldwide.

摘要

慢性肾脏病现已被公认为是一个全球性问题,与严重的发病率和死亡率相关,且进入终末期肾病的患者数量急剧增加。在世界许多地区,该疾病影响着没有糖尿病或高血压的年轻人。其对家庭和社会造成的成本可能巨大。早期识别慢性肾脏病可能有助于预防疾病进展以及随后的健康和寿命下降。一些国家已开始实施早期慢性肾脏病检测的监测项目。在本文中,我们将聚焦于这些项目面临的挑战和取得的成功,希望它们最终能得到广泛应用,从而减少全球范围内与慢性肾脏病相关的并发症、死亡、残疾和经济负担。

相似文献

1
Taming the chronic kidney disease epidemic: a global view of surveillance efforts.
Kidney Int. 2014 Aug;86(2):246-50. doi: 10.1038/ki.2014.190. Epub 2014 Jun 4.
2
Organization and Structures for Detection and Monitoring of CKD Across World Countries and Regions: Observational Data From a Global Survey.
Am J Kidney Dis. 2024 Oct;84(4):457-468.e1. doi: 10.1053/j.ajkd.2024.03.024. Epub 2024 May 22.
4
Chronic kidney disease epidemic: How do we deal with it?
Nephrology (Carlton). 2018 Oct;23 Suppl 4:116-120. doi: 10.1111/nep.13464.
5
Prevention programs for chronic kidney disease in low-income countries.
Intern Emerg Med. 2016 Apr;11(3):385-9. doi: 10.1007/s11739-016-1425-7. Epub 2016 Mar 16.
6
Chronic kidney disease: a hidden epidemic.
Prilozi. 2008 Jul;29(1):5-9.
7
Prevalence and Disease Burden of Chronic Kidney Disease.
Adv Exp Med Biol. 2019;1165:3-15. doi: 10.1007/978-981-13-8871-2_1.
9
Screening for Kidney Disease in Low- and Middle-Income Countries.
Semin Nephrol. 2022 Sep;42(5):151315. doi: 10.1016/j.semnephrol.2023.151315. Epub 2023 Mar 29.
10
Paediatric chronic kidney disease.
S Afr Med J. 2015 Apr;105(4):316-9. doi: 10.7196/samj.9532.

引用本文的文献

1
Machine learning-based identification and validation of amino acid metabolism related genes as novel biomarkers in chronic kidney disease.
Heliyon. 2025 Jan 10;11(2):e41872. doi: 10.1016/j.heliyon.2025.e41872. eCollection 2025 Jan 30.
3
Beyond Redox Regulation: Novel Roles of TXNIP in the Pathogenesis and Therapeutic Targeting of Kidney Disease.
Am J Pathol. 2025 Apr;195(4):615-625. doi: 10.1016/j.ajpath.2024.12.011. Epub 2025 Jan 13.
5
Surveillance of Noncommunicable Diseases: Opportunities in the Era of Big Data.
Health Data Sci. 2022 Jun 1;2022:9893703. doi: 10.34133/2022/9893703. eCollection 2022.
9
Comparison of trend in chronic kidney disease burden between China, Japan, the United Kingdom, and the United States.
Front Public Health. 2022 Sep 6;10:999848. doi: 10.3389/fpubh.2022.999848. eCollection 2022.
10
Blocking CHOP-dependent TXNIP shuttling to mitochondria attenuates albuminuria and mitigates kidney injury in nephrotic syndrome.
Proc Natl Acad Sci U S A. 2022 Aug 30;119(35):e2116505119. doi: 10.1073/pnas.2116505119. Epub 2022 Aug 22.

本文引用的文献

2
Chronic kidney disease: global dimension and perspectives.
Lancet. 2013 Jul 20;382(9888):260-72. doi: 10.1016/S0140-6736(13)60687-X. Epub 2013 May 31.
3
The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5.
Nephrol Dial Transplant. 2013 Aug;28(8):2107-16. doi: 10.1093/ndt/gft093. Epub 2013 May 7.
4
Clinical correlates of ambulatory BP monitoring among patients with CKD.
Clin J Am Soc Nephrol. 2013 May;8(5):721-30. doi: 10.2215/CJN.06470612. Epub 2013 Feb 14.
5
Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease.
Clin Exp Nephrol. 2013 Oct;17(5):730-742. doi: 10.1007/s10157-012-0758-4. Epub 2013 Jan 16.
7
CKD.QLD: chronic kidney disease surveillance and research in Queensland, Australia.
Nephrol Dial Transplant. 2012 Oct;27 Suppl 3(Suppl 3):iii139-45. doi: 10.1093/ndt/gfs258.
8
Factors associated with chronic kidney disease progression in Australian nephrology practices.
Nephron Clin Pract. 2012;121(1-2):c36-41. doi: 10.1159/000342375. Epub 2012 Oct 19.
9
Chronic kidney disease: Health burden of kidney disease recognized by UN.
Nat Rev Nephrol. 2011 Dec 6;8(1):12-3. doi: 10.1038/nrneph.2011.191.
10
The contribution of chronic kidney disease to the global burden of major noncommunicable diseases.
Kidney Int. 2011 Dec;80(12):1258-70. doi: 10.1038/ki.2011.368. Epub 2011 Oct 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验